α1-antichymotrypsin gene (SERPINA3) A/T polymorphism as a risk factor for aneurysmal subarachnoid hemorrhage

Stroke

Volumn 36, Issue 4, 2005, Pages 737-740

  Slowik, Agnieszka ^a   Borratynska, Anna ^a   Turaj, Wojciech ^a   Pera, Joanna ^a   Dziedzic, Tomasz ^c   Figlewicz, Denise A ^b   Betlej, Marek ^a   Krzyszkowski, Tadeusz ^a   Czepko, Ryszard ^a   Szczudlik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NONE

Author keywords

Alpha 1 antichymotrypsin; Polymorphism; SERPINA3; Subarachnoid hemorrhage

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; CATHEPSIN G; SERINE PROTEINASE INHIBITOR; ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; CATHEPSIN; SERINE PROTEINASE;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BRAIN ARTERY ANEURYSM; CHRONIC INFLAMMATION; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SERPINA 3 GENE; SUBARACHNOID HEMORRHAGE; EXTRACELLULAR MATRIX; GENETICS; INFLAMMATION; METABOLISM; POLAND; REGRESSION ANALYSIS; RISK;

ALLELES; ALPHA 1-ANTITRYPSIN; C-REACTIVE PROTEIN; CATHEPSINS; EXTRACELLULAR MATRIX; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFLAMMATION; MALE; ODDS RATIO; POLAND; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RISK; RISK FACTORS; SERINE ENDOPEPTIDASES; SUBARACHNOID HEMORRHAGE;

EID: 20144389704     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000157598.02014.37     Document Type: Article

References (28)

1. Kalsheker NA. Alpha 1-antichymotrypsin. Int J Biochem Cell Biol. 1996;28:961-964.
2. Licastro F, Pedrini S, Ferri C, Casadei V, Govoni M, Pession A, Sciacca FL, Veglia F, Annoni G, Bonafe M, Olivieri F, Franceschi C, Grimaldi LM. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann Neurol. 2000;48:388-391.
3. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nat Genet. 1995;10:486-488.
4. Morgan K, Licastro F, Tilley L, Ritchie A, Morgan L, Pedrini S, Kalsheker N. Polymorphism in the alpha(1)-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations. Hum Genet. 2001;109:303-310.
5. Broderick JP, Viscoli CM, Brott T, Keman WN, Brass LM, Feldmann E, Morgenstern LB, Wilterdink JL, Horwitz RI; Hemorrhagic Stroke Project Investigators. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke. 2003;34:1375-1381.
6. Wills S, Ronkainen A, van der Voet M, Kuivaniemi H, Helin K, Leinonen E, Frosen J, Niemela M, Jaaskelainen J, Hernesniemi J, Tromp G. Familial intracranial aneurysms: an analysis of 346 multiplex Finnish families. Stroke. 2003;34:1370-1374.
7. Slowik A, Borratynska A, Pera J, Betlej M, Dziedzic T, Krzyszkowski T, Czepko R, Figlewicz DA, Szczudlik A. II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm. Stroke. 2004;35:1594-1597.
8. van der Voet M, Olson JM, Kuivaniemi H, Dudek DM, Skunca M, Ronkainen A, Niemela M, Jaaskelainen J, Hernesniemi J, Helin K, Leinonen E, Biswas M, Tromp G. Intracranial aneurysms in Finnish families: confirmation of linkage and refinement of the interval to chromosome 19q13.3. Am J Hum Genet. 2004;74:564-571.
9. Onda H, Kasuya H, Yoneyama T, Takakura K, Hori T, Takeda J, Nakajima T, Inoue I. Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet. 2001;69:804-819.
10. Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R. Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke. 1999;30:1396-1401.
11. Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and intracranial aneurysms. Neurosurgery. 1999;45:1137-1146.
12. Peters DG, Kassam AB, Feingold E, Heidrich-O'Hare E, Yonas H, Ferrell RE, Brufsky A. Molecular anatomy of an intracranial aneurysm: coordinated expression of genes involved in wound healing and tissue remodeling. Stroke. 2001;32:1036-1042.
13. Krex D, Schackert HK, Schackert G. Genesis of cerebral aneurysms-an update. Acta Neurochir (Wien). 2001;143:429-448.
14. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest. 1998;102:576-583.
15. Vila N, Obach V, Revilla M, Oliva R, Chamorro A. Alpha(1)- antichymotrypsin gene polymorphism in patients with stroke. Stroke. 2000;31:2103-2105.
16. Ambrosius WT, Lange EM, Langefeld CD. Power for genetic association studies with random allele frequencies and genotype distributions. Am J Hum Genet. 2004;74:683-693.
17. McIlroy SP, Vahidassr MD, Savage DA, Lloyd F, Patterson CC, Lawson JT, Passmore AP. Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland. Int J Geriatr Psychiatry. 2000;15:260-266.
18. Lieberman J, Schleissner L, Tachiki KH, Kling AS. Serum alpha 1-antichymotrypsin level as a marker for Alzheimer-type dementia. Neurobiol Aging. 1995;16:747-753.
19. Wang X, DeKosky ST, Luedecking-Zimmer E, Ganguli M, Kamboh IM. Genetic variation in alpha (1)-antichymotrypsin and its association with Alzheimer's disease. Hum Genet. 2002;110:356-365.
20. Owen CA, Campbell EJ. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition. J Immunol 1998;160:1436-1443.
21. Janciauskiene S. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochim Biophys Acta. 2001;1535:221-235.
22. Ohkuma H, Suzuki S, Fujita S, Nakamura W. Role of a decreased expression of the local renin-angiotensin system in the etiology of cerebral aneurysms. Circulation. 2003;108:785-787.
23. Wang X, DeKosky ST, Ikonomovic MD, Kamboh MI. Distribution of plasma alpha 1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls. Neurobiol Aging. 2002;23:377-382.
24. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch Neurol 2004;61:668-672.
25. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D'Agostino RB, Franzblau C, Wilson PW. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study. Stroke. 2001;32:2575-2579.
26. Kurth T, Kase CS, Berger K, Gaziano JM, Cook NR, Buring JE. Smoking and risk of hemorrhagic stroke in women. Stroke. 2003;34:2792-2795.
27. Juvela S, Hillbom M, Numminen H, Koskinen P. Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 1993;24:639-646.
28. Teunissen LL, Rinkel GJ, Algra A, van Gijn J. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke. 1996;27:544-549.